Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avid Radiopharmaceuticals Inc.

Division of Eli Lilly & Co.
www.avidrp.com

Latest From Avid Radiopharmaceuticals Inc.

Keeping Track: Tauvid, Oriahnn, Artesunate Clear US FDA, Along With Trio Of Pediatric Approvals

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Approvals US FDA Performance Tracker

Keeping Track: US FDA Clears Oncologics Tukysa And Jelmyto; Regeneron Anti-Ebola Cocktail Under Review

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals

US FDA Exploring Virtual Advisory Cmtes.; Might Sponsors Want To Wait For In-Person Meetings?

Likelihood of webcast-only advisory committee meetings may depend on the extent of the coronavirus outbreak, Office of New Drugs Director Peter Stein tells the Pink Sheet in an interview.

Coronavirus COVID-19 Advisory Committees

As US FDA Settles Into Teleworking, Will Application Reviews Be Affected?

Productivity may suffer under coronavirus-mandated telework despite workforce diligence, experts say.

Coronavirus COVID-19 Drug Review
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eli Lilly & Co.
  • Senior Management
  • Daniel Skovronsky, MD, PhD, CEO
    Michael J Pontecorvo, PhD, VP, Clin. Dev.
    Mark A Mintun, MD, CMO
  • Contact Info
  • Avid Radiopharmaceuticals Inc.
    Phone: (215) 298-0700
    3711 Market St., 7th Fl.
    Philadelphia, PA 19104
    USA
UsernamePublicRestriction

Register